Breast Cancer Control Policy

Objectives

The Breast Cancer Control Policy establishes a national, standards-based framework to reduce breast cancer morbidity and mortality, improve quality of life, and ensure equitable, timely and high-quality prevention, diagnosis, treatment, survivorship and palliative care across South Africa.[1][2][3]It aligns breast cancer control with Sustainable Development Goal 3, the National Development Plan 2030 and National Health Insurance reform.[4][5]

• Integrate breast cancer prevention with chronic disease prevention, reproductive health, hepatitis B immunisation, HIV/AIDS, occupational health and environmental health services.[3]
• Improve awareness and early recognition through community education, breast-health information, clinical breast examination and prompt presentation for breast symptoms.[2][6][7][8]
• Provide risk assessment, genetic counselling, testing and specialist management for women with familial cancer risk or known or suspected breast cancer susceptibility gene mutations.[9][10][11]
• Establish Specialist Breast Units and Provincial Oncology Units that deliver coordinated multidisciplinary care for benign and malignant breast disease.[12][13]
• Ensure rapid referral, diagnosis and treatment, including a target for 90% of patients to begin treatment within 60 days of first presentation and definitive treatment within 31 days of the decision to treat for confirmed cancer.[14]
• Deliver triple assessment, staging, surgery, systemic therapy, radiotherapy, reconstruction, psychosocial support, patient navigation, palliative care, follow-up and lymphoedema care according to national standards.[6][15][16][17][18][19]
• Improve data, research, service monitoring and community engagement to assess treatment quality, survival, stage at diagnosis, treatment timelines and programme impact.[2][20][21]

The policy seeks to reduce delays and advanced-stage presentation, improve survival and treatment effectiveness, protect quality of life during survivorship and palliation, and provide care irrespective of geographical location or social circumstances.[2][3]It recognises breast cancer as a national priority and the most prevalent cancer among South African women.[1]

Implementation

Implementation is based on an integrated, tiered care model spanning communities, primary healthcare, district hospitals, Specialist Breast Units, Provincial Oncology Units, tertiary and quaternary services, with referral pathways designed to move patients quickly to the appropriate level of care.[5][13][22]Provinces may adapt service configurations to local population density, capacity and need while applying national standards of care.[3][13][23]

• Train primary healthcare nurses, doctors and community healthcare workers in breast awareness, clinical breast examination, risk assessment, symptom recognition, counselling and referral.[7][24][22][21]
• Use specialist units as centres for triple assessment, image-guided biopsy, benign and malignant breast surgery, staging, counselling, staff training, outreach, survivorship support and palliative-care coordination.[13][22][25]
• Provide Provincial Oncology Unit services for specialised medical oncology, chemotherapy, biological therapies, radiation oncology, specialised radiology and nuclear medicine that cannot be delivered at lower levels.[12][22][26]
• Coordinate decisions through multidisciplinary teams including breast surgeons, oncologists, radiologists, pathologists, geneticists, nurses, psychosocial professionals, rehabilitation providers and palliative-care personnel.[1][3][23]
• Use patient navigators, referral forms, checklists, integrated records, transfer protocols and patient transport to reduce missed appointments, inappropriate referrals and treatment delays.[12][13][24][14]
• Engage civil society organisations, advocacy groups, community leaders, traditional healers, religious leaders and programme champions in culturally appropriate information, education and communication activities.[3][20][21]
• Give particular consideration to women living with HIV, sex workers, adolescents, migrants, rural communities and women facing socio-economic barriers to information and services.[2][5]

National leadership is coordinated through the National Department of Health, supported by national health services, laboratory partners, civil society organisations and technical experts.[27]The National Health Insurance reform is intended to support service reorganisation and access based on health need rather than socio-economic status.[5]

Operational accountability relies on standards-derived performance indicators, continuous facility audit, coordinated provincial review and electronic data systems.[3][13][20]Facilities are expected to collect breast cancer data from diagnosis onwards, supported by data managers responsible for data quality, ethical use and audit responses.[20]Specialist breast units should maintain registries and audit databases covering referral source, diagnosis, pathology, treatment, outcomes and diagnostic timeliness, with independent audit against national guidelines.[28]

Key performance measures include treatment and diagnostic timelines, completion of triple assessment, uptake of genetic counselling and screening among eligible women, reconstruction discussions and procedures, initiation of neo-adjuvant therapy, follow-up activity and outcomes such as survival, stage at presentation, quality of life, morbidity and mortality.[2][10][29][30][31][32][18]The source does not specify a consolidated implementation timetable, a full assignment of institutional responsibilities, or a quantified national budget.[33][34][18]

Monitoring & Evaluation

The policy establishes a broad monitoring, evaluation and accountability approach combining cancer registration, facility-level data systems, clinical quality assurance, service audits and time-based performance standards. It seeks to monitor programme implementation and impact through outcomes including survival, morbidity and mortality, stage at presentation, time to presentation and treatment, and quality of life.[2]

• Maintain national cancer surveillance through the National Cancer Registry, a specialised division of the National Health Laboratory Services, which collates cancer morbidity using methods aligned with the World Health Organization and International Agency for Research on Cancer.[35]Cancer statistics include lifetime risk, age-standardised incidence rates per 100,000 population and age-specific incidence rates.[35][36]
• Strengthen data quality because breast cancer incidence is under-reported, population-based information is lacking, and the pathology-based National Cancer Registry is not up to date.[2]Collect data from diagnosis onwards in an electronic database, appoint data managers for quality assurance, ethical use and audit responses, and use breast cancer, population-based cancer and mortality registries to support planning and research.[20]
• Collect incidence, mortality, stage at diagnosis, tumour size, survival by stage and treatment-timeliness data to assess burden, monitor treatment quality, identify priorities and guide health-system improvements.[20]
• Derive key performance indicators from national standards of care, apply monitoring and evaluation points to service performance, and enable continuous facility audits coordinated within and between provinces.[3]Audit standards and outcomes through the proposed care-standard auditing framework.[2]
• Monitor referral, diagnosis and treatment timelines, including the target that 90% of patients begin treatment within 60 days of first presentation, definitive treatment within 31 days of the decision to treat, and first adjuvant therapy within 60 days of surgery and no later than 90 days.[14]Complete routine diagnostic work-up within two weeks at specialist and provincial oncology levels.[22][26]
• Target more than 80% of patients completing triple assessment within 21 days and audit the proportion completing appropriate triple assessment.[30]Monitor the time from first presentation to definitive diagnosis and first multidisciplinary-team consultation, with a maximum target of four weeks in specialised units.[28]
• Use referral forms, checklists, standardised proformas, integrated records and computerised breast software to document care pathways, support multidisciplinary access to information, audit referrals and assess implementation of standards.[13][24][22][26]
• Maintain laboratory quality assurance through synoptic pathology reporting, daily immunohistochemistry checks, external quality-assurance programmes and availability of quality-assurance results to clinicians and pathologists.[25][37]
• Record service-specific measures, including biannual uptake among women eligible for genetic services, referrals for genetic assessment, annual genetic counselling and screening among eligible mutation carriers, reconstruction activity and whether reconstruction discussions are recorded in medical notes.[10][38][29][11][17]
• Monitor delivery of neo-adjuvant therapy for eligible locally advanced breast cancer within 30 days of diagnosis, eligibility for surgery after therapy, proportions simulated within 60 days and treatment completed within 120 days, and follow-up through local protocols and annual mammography for early and locally advanced disease.[32][18][39]
• Support accountability through independent audits of specialised breast and primary oncology units, verification of compliance with national guidelines, appointed data managers and tracing of patients who miss appointments through their primary referral centres.[28][23]

Although the policy identifies numerous monitoring points and clinical measures, many sections do not define indicator specifications, data sources, reporting schedules, responsible reporting bodies, evaluation methodologies or formal accountability processes.[3][8][40]

Costing & Financing

The policy recognises that breast cancer control requires substantial resources in a low- and middle-income setting with competing health priorities, while promoting affordable, sustainable and resource-appropriate care.[5][7]It does not provide a quantified overall budget, costed implementation plan, funding-gap analysis, financing allocation or resource-mobilisation strategy.[12][13][24]

• Use National Health Insurance as a financing reform intended to provide affordable, quality services according to health need rather than socio-economic status.[5]
• Provide specialised budgets for chemotherapy and biological therapies at Provincial Oncology Units, although no budget amount, currency, funding source or allocation mechanism is specified.[26][14]
• Prioritise clinical breast examination and targeted awareness activities as lower-cost approaches to early detection.[7]Clinical breast examination by ancillary health workers is presented as potentially nearly as effective as biennial mammography in developing countries at substantially lower cost.[7]
• Restrict introduction of screening mammography to settings with resources sufficient for effective and reliable coverage of at least 70% of women aged 50 years and older.[8]Mammography requires substantial financial and human-resource inputs.[8]
• Mobilise government budgets and non-governmental organisations to support patient navigators, community clinical breast examinations, referral assistance and information transfer.[13][24]
• Resource specialist breast and provincial oncology services with multidisciplinary staff, equipment, training, information systems, transport and dedicated data-management capacity, without stated monetary values.[12][13][24][20]
• Recognise that the cost of HER2-targeted treatment constrains access internationally and in South Africa.[41]Treatment selection for metastatic disease may also depend on drug availability and affordability.[42]
• Support palliative care through affordable opioid access, trained personnel and home-care programmes, which are described as feasible and cost-effective in low-resource contexts.[39]
• Implement community education campaigns at low or minimal cost, while using civil society organisations, community health workers and local leaders to extend outreach.[21]
• Maintain a minimum annual caseload of 150 newly diagnosed primary breast cancer cases in specialised breast units, linking this threshold to cost-effective unit functioning but without a monetary estimate.[28]

Beyond these resource directions, no explicit economic assumptions, unit costs, affordability thresholds other than screening capacity, funding gaps or detailed financing arrangements are specified.[8][19][20]